XOMA Corp (XOMA)
25.42
+1.72
(+7.28%)
USD |
NASDAQ |
May 10, 16:00
25.42
0.00 (0.00%)
After-Hours: 20:00
XOMA Enterprise Value: 246.07M for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 246.07M |
| May 08, 2024 | 252.00M |
| May 07, 2024 | 255.72M |
| May 06, 2024 | 261.54M |
| May 03, 2024 | 258.75M |
| May 02, 2024 | 266.42M |
| May 01, 2024 | 270.84M |
| April 30, 2024 | 265.26M |
| April 29, 2024 | 278.74M |
| April 26, 2024 | 266.07M |
| April 25, 2024 | 265.49M |
| April 24, 2024 | 268.74M |
| April 23, 2024 | 273.98M |
| April 22, 2024 | 270.84M |
| April 19, 2024 | 266.88M |
| April 18, 2024 | 256.54M |
| April 17, 2024 | 252.58M |
| April 16, 2024 | 254.10M |
| April 15, 2024 | 253.63M |
| April 12, 2024 | 271.19M |
| April 11, 2024 | 275.26M |
| April 10, 2024 | 270.37M |
| April 09, 2024 | 268.40M |
| April 08, 2024 | 264.09M |
| April 05, 2024 | 265.26M |
| Date | Value |
|---|---|
| April 04, 2024 | 270.60M |
| April 03, 2024 | 270.95M |
| April 02, 2024 | 277.00M |
| April 01, 2024 | 264.21M |
| March 28, 2024 | 250.26M |
| March 27, 2024 | 242.01M |
| March 26, 2024 | 239.80M |
| March 25, 2024 | 249.68M |
| March 22, 2024 | 258.98M |
| March 21, 2024 | 255.84M |
| March 20, 2024 | 256.89M |
| March 19, 2024 | 263.63M |
| March 18, 2024 | 263.40M |
| March 15, 2024 | 276.65M |
| March 14, 2024 | 270.26M |
| March 13, 2024 | 268.40M |
| March 12, 2024 | 268.86M |
| March 11, 2024 | 276.18M |
| March 08, 2024 | 257.93M |
| March 07, 2024 | 262.70M |
| March 06, 2024 | 261.30M |
| March 05, 2024 | 256.54M |
| March 04, 2024 | 260.96M |
| March 01, 2024 | 256.90M |
| February 29, 2024 | 250.11M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
98.41M
Minimum
Sep 13 2022
486.94M
Maximum
Dec 21 2020
202.90M
Average
186.38M
Median
Enterprise Value Benchmarks
| Kinnate Biopharma Inc (DELISTED) | -28.89M |
| Societal CDMO Inc (DELISTED) | 145.26M |
| Corcept Therapeutics Inc | 2.361B |
| Sarepta Therapeutics Inc | 12.35B |
| AnaptysBio Inc | 311.09M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -20.11M |
| Revenue (Quarterly) | 1.833M |
| Total Expenses (Quarterly) | 7.514M |
| EPS Diluted (Quarterly) | -1.87 |
| Profit Margin (Quarterly) | -1.10K% |
| Earnings Yield | -15.90% |
| Normalized Earnings Yield | -9.598 |